In 2012, At Ease USA and Creighton University partnered together to launch a clinical trial of a promising new therapeutic intervention. The therapy called “Attention Bias Modification Treatment,” or ABMT, was developed by Dr. Yair Bar-Haim, Professor of Psychology and Neuroscience, and Head of the School of Psychological Sciences at Tel Aviv University, who was in Omaha for the launch of this research.  Since that time, the results of those initial trials have been published in multiple journals.

Because of the success of this first trial, At Ease USA and Creighton University are continuing their partnership to undertake the next phase of testing Attention Control Training.